Latest Views & News

To Buy or To Sell Avacta? That is the Question…

By Malcolm Stacey | Monday 18 May 2020

Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

Hello, Share Shifters. I find myself on the horns of a horrible dilemma. And once again, it’s due to Uncle Tom Winnifrith. He has written a couple of immaculately researched pieces on this legendary website warning that a company in my portfolio is overvalued. Indeed, he says the valuation of medical pioneer Avacta (AVCT) is 'bonkers'...

You must be a registered member to read this story
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £5.99 per month for all articles, the Bearcast, and our seven year archive.

Filed under:

Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Monday »


Just 26 days to go: Book Now!

Sunday »


Me and “The Millionaire Next Door”

Tuesday »


Synectics – a recovery Buy?



Malcolm Stacey is Moving House

Monday »


Wood Group - a Buy (again)?



Video: Bubbles always implode